GenAI in Tech & Cyber Due Diligence: 10 Practical Uses That Don't Require You to Sacrifice Data Control

Generative AI adoption in M&A has moved from pilot programs to embedded workflows in under 18 months. According to Deloitte's 2025 GenAI in M&A Survey of 1,000 senior corporate and PE leaders, 86% of responding organizations have integrated GenAI into their M&A processes, and 83% have invested $1 million or more specifically for deal team use cases. McKinsey's survey of active users reports an average cost reduction of approximately 20% and deal cycle compression of 30-50% among 40% of respondents. The technology works. The question for deal teams is no longer whether to use it: it's how to use it without creating a data governance problem that undermines the deal itself.

Key Takeaways

• 86% of corporate and PE organizations have integrated GenAI into M&A workflows; 65% did so within the past year (Deloitte, 2025)
• 67% of respondents cite data security as the leading barrier to broader GenAI adoption in deal processes (Deloitte, 2025)
• 12.6% of all sensitive data exposures in GenAI tools involved M&A data, the third-highest category after code and legal discourse (Harmonic Security, January 2026)
• Gartner forecasts that by 2027, more than 40% of AI-related data breaches will stem from cross-border GenAI misuse
• Deal teams that embed GenAI into existing secure infrastructure instead of layering consumer tools on top reduce exposure while capturing the efficiency gains

The Governance Gap Is the Real Risk

The adoption curve is steep, but the controls haven't kept pace. Deloitte's survey found 67% of respondents flagging data security as a leading concern, followed by data quality and availability at 65%. A January 2026 analysis by Harmonic Security of 22.4 million GenAI prompts across six major platforms found that 2.6% contained company-sensitive data. M&A data accounted for 12.6% of all sensitive exposures, behind only source code and legal documents. Critically, 17% of exposures occurred through personal or free-tier accounts with zero organizational visibility.

The risk isn't that an analyst uses AI to summarize a management presentation. The risk is that they paste EBITDA schedules, customer lists, or proprietary technology assessments into a consumer-grade tool that may retain inputs for model training, lacks enterprise audit trails, and operates outside the deal's confidentiality perimeter. In a competitive process, that's a breach of the NDA before the LOI is signed.

10 Practical Applications Across the Deal Lifecycle

The following use cases map to where GenAI delivers measurable value in tech and cyber due diligence, paired with the data governance control that makes each one defensible.

The Control Framework: Three Non-Negotiable Principles

Every use case above follows three principles that separate defensible AI adoption from liability creation.

Data stays inside the deal perimeter. If the AI tool processes deal-confidential information, it must operate within an environment covered by the deal's NDA, the VDR provider's security certifications, or the acquirer's enterprise infrastructure. Consumer-grade AI tools, regardless of provider, are outside this perimeter.

Audit trails exist for every interaction. Every AI-assisted analysis must produce a traceable record: what data went in, what the model produced, when, and by whom. This is not optional. It's required for LP reporting, co-investor due diligence defense, and regulatory compliance under the EU AI Act's transparency requirements.

Human review is the final gate. GenAI accelerates analysis. It does not make investment decisions. Every AI-generated finding (contract risk, compliance gap, financial anomaly) must be validated by a qualified professional before it informs deal economics or investment committee materials. The 35% of organizations still hesitating over GenAI error rates (Deloitte, 2025) are right to exercise caution, but the answer is human-in-the-loop governance, not avoidance.

What This Means for Deal Teams Now

The firms capturing the most value from GenAI in due diligence are not the ones with the most advanced tools. They're the ones with the clearest governance frameworks: which tools are approved before the deal, where data can flow, who reviews AI outputs, and how exceptions are escalated.

For the broader AI data governance framework that applies beyond M&A contexts, see AI data governance: the same problem enterprises already solved. For deal teams evaluating targets that deploy AI agents, which introduce security considerations beyond traditional GenAI tools, see the enterprise AI agent security risks and the security-first deployment framework. For the complete M&A due diligence methodology, see our practitioner's framework for cybersecurity due diligence.

The full Intelligence Brief covers the complete use case matrix with data governance controls, a GenAI tool evaluation framework, a deal-stage adoption roadmap, and a ready-to-use AI governance policy template for deal teams.